Paula B. Caffrey
About
In The Last Decade
Paula B. Caffrey
22 papers receiving 331 citations
Peers
Comparison fields: 5 of 73
- Nutrition and Dietetics 161
- Molecular Biology 100
- Health, Toxicology and Mutagenesis 80
- Oncology 49
- Pathology and Forensic Medicine 43
Countries citing papers authored by Paula B. Caffrey
This map shows the geographic impact of Paula B. Caffrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula B. Caffrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula B. Caffrey more than expected).
Fields of papers citing papers by Paula B. Caffrey
This network shows the impact of papers produced by Paula B. Caffrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula B. Caffrey. The network helps show where Paula B. Caffrey may publish in the future.
Co-authorship network of co-authors of Paula B. Caffrey
This figure shows the co-authorship network connecting the top 25 collaborators of Paula B. Caffrey. A scholar is included among the top collaborators of Paula B. Caffrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula B. Caffrey. Paula B. Caffrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | Prevention of carboplatin-induced resistance in human ovarian tumor xenografts by selenite. | 18 |
| 5 | A phase I and pharmacokinetic study of paclitaxel and carboplatin combined with sodium selenite in patients with gynecologic malignacies | 1 |
| 6 | Prevention of carboplatin-induced resistance in human ovarian tumor xenografts | 3 |
| 7 | 16 | |
| 8 | 42 | |
| 9 | 53 | |
| 10 | 13 | |
| 11 | 8 | |
| 12 | Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo. | 2 |
| 13 | 21 | |
| 14 | 19 | |
| 15 | 1 | |
| 16 | 11 | |
| 17 | 14 | |
| 18 | 6 | |
| 19 | 29 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.